Efficacy and safety of Xiaoyao pills for mild to moderate depression: study protocol for a randomized controlled trial

Abstract Background Depression is one of the most frequent and severe psychiatric conditions. Many chemical drugs to treat depression are associated with adverse reactions and have shortcomings. Traditional Chinese medicine is of great significance in the prevention and treatment of depression. Xiao...

Full description

Bibliographic Details
Main Authors: Zhe Xue, Zhen Huang, Shu-li Cheng, Xi-hong Wang, Xuan Zhou, Qing-yu Ma, Jia-xu Chen
Format: Article
Language:English
Published: BMC 2022-01-01
Series:Trials
Subjects:
Online Access:https://doi.org/10.1186/s13063-021-05909-y
_version_ 1818941682767364096
author Zhe Xue
Zhen Huang
Shu-li Cheng
Xi-hong Wang
Xuan Zhou
Qing-yu Ma
Jia-xu Chen
author_facet Zhe Xue
Zhen Huang
Shu-li Cheng
Xi-hong Wang
Xuan Zhou
Qing-yu Ma
Jia-xu Chen
author_sort Zhe Xue
collection DOAJ
description Abstract Background Depression is one of the most frequent and severe psychiatric conditions. Many chemical drugs to treat depression are associated with adverse reactions and have shortcomings. Traditional Chinese medicine is of great significance in the prevention and treatment of depression. Xiaoyao pills has achieved good results in clinical application, which has the advantages of quick effect and no obvious adverse reactions. The aim of our study is to evaluate the efficacy and safety of Xiaoyao pills on mild to moderate depression patients. Methods This study is a multi-centre, double-blinded, randomized and placebo-controlled clinical trial. A total of 108 participants are assigned to three groups: Xiaoyao pill group taking Xiaoyao pills twice daily for 4 weeks, placebo group taking placebos twice daily for 4 weeks and normal group without taking any drug. The primary and secondary outcome measures are the Hamilton Depression Scale (HAMD) and Traditional Chinese Medicine (TCM) Syndrome Scale. The assessment is at baseline (before treatment initiation), 1 week, 2 weeks 4 weeks after the first treatment. Exploratory outcome is also assessed to explore the mechanism of Xiaoyao pills at baseline and 4 weeks. Discussion The results from this study will provide clinical evidence on the efficacy and safety of Xiaoyao pills in patients with mild to moderate depression with syndrome of liver stagnation and spleen deficiency. Trial registration ClinicalTrials.gov ISRCTN12746343. Registered on September 25, 2020.
first_indexed 2024-12-20T06:59:25Z
format Article
id doaj.art-9c2e203cc67f41909c67ed0f01570ccc
institution Directory Open Access Journal
issn 1745-6215
language English
last_indexed 2024-12-20T06:59:25Z
publishDate 2022-01-01
publisher BMC
record_format Article
series Trials
spelling doaj.art-9c2e203cc67f41909c67ed0f01570ccc2022-12-21T19:49:14ZengBMCTrials1745-62152022-01-0123111210.1186/s13063-021-05909-yEfficacy and safety of Xiaoyao pills for mild to moderate depression: study protocol for a randomized controlled trialZhe Xue0Zhen Huang1Shu-li Cheng2Xi-hong Wang3Xuan Zhou4Qing-yu Ma5Jia-xu Chen6School of Traditional Chinese Medicine, Beijing University of Chinese MedicineSchool of Traditional Chinese Medicine, Beijing University of Chinese MedicineSchool of Traditional Chinese Medicine, Beijing University of Chinese MedicineSchool of Traditional Chinese Medicine, Beijing University of Chinese MedicineGuangzhou Key Laboratory of Formula-Pattern of Traditional Chinese Medicine, School of Traditional Chinese Medicine, Jinan UniversityGuangzhou Key Laboratory of Formula-Pattern of Traditional Chinese Medicine, School of Traditional Chinese Medicine, Jinan UniversitySchool of Traditional Chinese Medicine, Beijing University of Chinese MedicineAbstract Background Depression is one of the most frequent and severe psychiatric conditions. Many chemical drugs to treat depression are associated with adverse reactions and have shortcomings. Traditional Chinese medicine is of great significance in the prevention and treatment of depression. Xiaoyao pills has achieved good results in clinical application, which has the advantages of quick effect and no obvious adverse reactions. The aim of our study is to evaluate the efficacy and safety of Xiaoyao pills on mild to moderate depression patients. Methods This study is a multi-centre, double-blinded, randomized and placebo-controlled clinical trial. A total of 108 participants are assigned to three groups: Xiaoyao pill group taking Xiaoyao pills twice daily for 4 weeks, placebo group taking placebos twice daily for 4 weeks and normal group without taking any drug. The primary and secondary outcome measures are the Hamilton Depression Scale (HAMD) and Traditional Chinese Medicine (TCM) Syndrome Scale. The assessment is at baseline (before treatment initiation), 1 week, 2 weeks 4 weeks after the first treatment. Exploratory outcome is also assessed to explore the mechanism of Xiaoyao pills at baseline and 4 weeks. Discussion The results from this study will provide clinical evidence on the efficacy and safety of Xiaoyao pills in patients with mild to moderate depression with syndrome of liver stagnation and spleen deficiency. Trial registration ClinicalTrials.gov ISRCTN12746343. Registered on September 25, 2020.https://doi.org/10.1186/s13063-021-05909-yTraditional Chinese MedicineDepressionRandomized controlled trial
spellingShingle Zhe Xue
Zhen Huang
Shu-li Cheng
Xi-hong Wang
Xuan Zhou
Qing-yu Ma
Jia-xu Chen
Efficacy and safety of Xiaoyao pills for mild to moderate depression: study protocol for a randomized controlled trial
Trials
Traditional Chinese Medicine
Depression
Randomized controlled trial
title Efficacy and safety of Xiaoyao pills for mild to moderate depression: study protocol for a randomized controlled trial
title_full Efficacy and safety of Xiaoyao pills for mild to moderate depression: study protocol for a randomized controlled trial
title_fullStr Efficacy and safety of Xiaoyao pills for mild to moderate depression: study protocol for a randomized controlled trial
title_full_unstemmed Efficacy and safety of Xiaoyao pills for mild to moderate depression: study protocol for a randomized controlled trial
title_short Efficacy and safety of Xiaoyao pills for mild to moderate depression: study protocol for a randomized controlled trial
title_sort efficacy and safety of xiaoyao pills for mild to moderate depression study protocol for a randomized controlled trial
topic Traditional Chinese Medicine
Depression
Randomized controlled trial
url https://doi.org/10.1186/s13063-021-05909-y
work_keys_str_mv AT zhexue efficacyandsafetyofxiaoyaopillsformildtomoderatedepressionstudyprotocolforarandomizedcontrolledtrial
AT zhenhuang efficacyandsafetyofxiaoyaopillsformildtomoderatedepressionstudyprotocolforarandomizedcontrolledtrial
AT shulicheng efficacyandsafetyofxiaoyaopillsformildtomoderatedepressionstudyprotocolforarandomizedcontrolledtrial
AT xihongwang efficacyandsafetyofxiaoyaopillsformildtomoderatedepressionstudyprotocolforarandomizedcontrolledtrial
AT xuanzhou efficacyandsafetyofxiaoyaopillsformildtomoderatedepressionstudyprotocolforarandomizedcontrolledtrial
AT qingyuma efficacyandsafetyofxiaoyaopillsformildtomoderatedepressionstudyprotocolforarandomizedcontrolledtrial
AT jiaxuchen efficacyandsafetyofxiaoyaopillsformildtomoderatedepressionstudyprotocolforarandomizedcontrolledtrial